New Delhi [India], May 19 (ANI): The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
Washington [US], May 19 (ANI): COVID-19 vaccines developed by Pfizer and Moderna work against B.1.617 variant of the virus that was first identified in India, according to a new study.
New Delhi [India], May 19 (ANI): Union Minister Nitin Gadkari on Tuesday said that more pharma companies should be allowed to manufacture the COVID-19 vaccine in the country during the pandemic to scale up production.
New Delhi [India], May 19 (ANI): Kenya's Deputy High Commissioner Irene Achieng Oloo accompanied her son as he received his first jab of COVID-19 vaccine at a vaccination centre in Delhi's Malviya Nagar on Tuesday.
New Delhi [India], May 19 (ANI): US pharmaceutical giant Johnson and Johnson has joined hands with Biological E Limited (Telangana-based pharma company) for the manufacturing of the COVID-19 vaccine, as per an official statement on Tuesday.
New Delhi [India], May 18 (ANI): The Central government has provided over 20.78 crore COVID-19 vaccine doses to states and Union Territories (UTs) so far.
Beijing [China], May 18 (ANI): Chinese infectious disease specialist has warned that slow global COVID-19 vaccine roll-out risks allowing new variants to emerge as the world continues to combat the pandemic.
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
New Delhi [India], May 18 (ANI): With the first dose of COVID-19 vaccination done for the Indian players who are set to travel to England for the World Test Championship (WTC) final and the five-match Test series against England, the second dose will be administered by the UK health departme
New Delhi [India], May 18 (ANI): The Delhi High Court on Tuesday directed the concerned authorities of the Centre and Delhi Government to treat a Public Interest Litigation (PIL) as a representation which sought direction for the supply of COVID-19 vaccines in Delhi with immediate effect.
Mumbai (Maharashtra) [India], May 18 (ANI/PNN): XL Dynamics India Pvt. Ltd. has announced that it will cover the Covid-19 vaccination cost for 5,000 people, including its employees and their dependent family members, as a part of its employee well-being program.